HOME
CAREERS
CONTACT US
PRIVACY POLICY
About
Team
Services
Clients
Events
Client Events
Conferences
Medical Conferences
Investor Conferences
Execution Driven Investor Relations
Tweets by @BlueprintLSG
Newsroom
U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer
Wednesday March 03, 2021
